VGF is known to work together with other granin proteins to regulate granule biogenesis in the trans Golgi network (TGN) 22
The FDA requires that weight loss drugs demonstrate a minimum of 5% weight loss compared to placebo over one year to gain approval
Nature Reviews Endocrinology , 17(7), 391-405
At a high level, GLP-1 receptor agonists (and dual agonists like tirzepatide) help with blood sugar and weight by improving insulin response, lowering glucagon (a hormone that raises blood sugar), and reducing appetite
Additionally, gentle physical activities like walking or stretching can help counteract the effects of tiredness, supporting overall weight loss efforts
The GLP-1 Revolution: How Appetite-Suppressing Drugs Are Changing Diets and Disrupting the Food Industry From fewer chips to more yogurt, discover how Ozempic and Wegovy are reshaping grocery carts, dining habits, and consumer behavior